Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Elevated levels of homocysteine a potential risk factor in AD

Oct. 22, 1998

Toyama licenses neuroprotective compound from Senju

Oct. 22, 1998

Lomerizine, a new antimigraine agent, compared to flunarizine in rats

Oct. 22, 1998

Dopaminergic and serotonergic agents synthesized at Lundbeck

Oct. 22, 1998

NOS inhibitors developed at Chugai reportedly useful for cerebrovascular disorders

Oct. 22, 1998

Pramipexole improves rest tremor in Parkinson's disease

Oct. 22, 1998

Linopirdine analogue proves to be more potent neurotransmitter release enhancer

Oct. 21, 1998

Versed Syrup approved for pediatric sedation

Oct. 21, 1998

MorphiDex NDA accepted for FDA review

Oct. 21, 1998

Potent CRF1 receptor antagonists and their use described by Yoshitomi

Oct. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...